Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 14;12:805883. doi: 10.3389/fimmu.2021.805883

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Liu, Cui, Shen, Gao, Zhu and Xu

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Associations of immune cell infiltration, immune checkpoints expression, and IPS and the EMT-related risk signature. (A) The distribution of immunomodulators in high-risk and low-risk groups. (B, C) The expression of 2 immune checkpoint molecules (CTLA4 and PD1) in high-risk and low-risk groups and Pearson’s correlation coefficient calculated between risk score and 2 immune checkpoint molecules. (D) The association between IPS and the risk score in EC patients. IPS, immune prognostic signature; EMT, epithelial–mesenchymal transition; EC, endometrial cancer.